Sign In
Buy BTCY
$0.103
+0.0072 (+7.56%)
At Close: Aug 10, 2026
Biotricity (OTCMKTS:BTCY) Coverage Initiated by Analysts at HC Wainwright
07:54am, Friday, 26'th Nov 2021 Transcript Daily
HC Wainwright initiated coverage on shares of Biotricity (OTCMKTS:BTCY) in a research report sent to investors on Tuesday, Analyst Ratings Network reports. The firm issued a buy rating and a $6.00 price target on the stock. Separately, Maxim Group restated a buy rating and set a $7.00 price objective on shares of Biotricity in a []
Biotricity's (BTCY) CEO Waqaas Al-Siddiq on Q2 2022 Results - Earnings Call Transcript
02:27am, Tuesday, 09'th Nov 2021
Biotricity's (BTCY) CEO Waqaas Al-Siddiq on Q2 2022 Results - Earnings Call Transcript
Biotricity to Report Second Quarter Fiscal 2022 Financial Results on November 4, 2021
08:45am, Tuesday, 02'nd Nov 2021
Management to Host Conference Call and Live Webcast at 5pm ET REDWOOD CITY, CA / ACCESSWIRE / November 2, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology
3 Biotech Penny Stocks to Watch That Are Climbing Right Now
12:28pm, Friday, 22'nd Oct 2021
Why investors are watching these biotech penny stocks right now The post 3 Biotech Penny Stocks to Watch That Are Climbing Right Now appeared first on Penny Stocks to Buy, Picks, News and Information
Biotricity to Discuss its Breakthrough Patient Monitoring Solutions at Virtual LD Micro Main Event XIV on Oct. 13th
09:15am, Tuesday, 12'th Oct 2021
REDWOOD CITY, CA / ACCESSWIRE / October 12, 2021 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that
Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series
08:16am, Friday, 08'th Oct 2021
REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ: BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Biocare Card
Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series
09:11am, Thursday, 07'th Oct 2021
REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Biocare Cardia
Remote Medical Diagnostic Company, Biotricity, to Ring the Nasdaq Stock Market Opening Bell on Thursday, October 7th
01:00pm, Wednesday, 06'th Oct 2021
Founder and CEO Waqaas Al Siddiq and Members of Biotricity Management Team to Attend Opening Bell Ceremony on Thursday, October 7, 2021 at 9:30am E.T. REDWOOD CITY, CA / ACCESSWIRE / October 6, 2021 /
Biokit is the Expansion of the Company's Bioflux Cardiac-Diagnostic Offering Kits on Track for Launch in Early 2022 REDWOOD CITY, CA / ACCESSWIRE / September 21, 2021 / Biotricity Inc. (NASDAQ:BTCY),
Biotricity Unveils "Biokit" with 3 Personal Medical Devices to Expand into Cardiac Disease Management
09:41am, Tuesday, 14'th Sep 2021
Company Expects New Personal Medical Device Kit to be available to customer by early 2022 REDWOOD CITY, CA / ACCESSWIRE / September 14, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and c
Biotricity Announces Closing of Exercise of Underwriter's Option to Purchase Additional Common Stock
08:00am, Monday, 13'th Sep 2021
Underwritten Public Offering of Common Stock Resulted in Total Gross Proceeds of $16 Million REDWOOD CITY, CA / ACCESSWIRE / September 13, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic a
Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference
08:00am, Wednesday, 08'th Sep 2021
Company's Momentum Continuing with Sales Growth, Recent Nasdaq listing and Successful Equity Raise REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or t
Biotricity Reports Q1 Earnings at 290% for FY2022
07:12am, Thursday, 02'nd Sep 2021
Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always connected, these wearable
Biotricity Uplists to Nasdaq, Poses Significant Buying Opportunity for Investors
09:06am, Wednesday, 01'st Sep 2021
Image via Biotricity.com Thursday, August 26, 2021, Biotricity, Inc. (NASDAQ: BTCY) uplisted to Nasdaq after raising $15 million to fuel its continued growth and expansion. Biotricity is a cardiac mon
Biotricity: Capital Raise Leads To Buying Opportunity
08:56pm, Monday, 30'th Aug 2021
BTCY recently announced a capital raise, leading to a sudden and significant decrease in the share price. With likely catalysts ahead, and continued stellar growth in its core business, the recent sha
